Show simple item record

dc.contributor.authorVoos, Katrin
dc.contributor.authorSchönauer, Esther
dc.contributor.authorAlhayek, Alaa
dc.contributor.authorHaupenthal, Jörg
dc.contributor.authorAndreas, Anastasia
dc.contributor.authorMüller, Rolf
dc.contributor.authorHartmann, Rolf W
dc.contributor.authorBrandstetter, Hans
dc.contributor.authorHirsch, Anna K H
dc.contributor.authorDucho, Christian
dc.date.accessioned2021-02-12T12:13:59Z
dc.date.available2021-02-12T12:13:59Z
dc.date.issued2021-01-27
dc.identifier.citationChemMedChem. 2021 Jan 27. doi: 10.1002/cmdc.202000994. Epub ahead of print.en_US
dc.identifier.pmid33506625
dc.identifier.doi10.1002/cmdc.202000994
dc.identifier.urihttp://hdl.handle.net/10033/622736
dc.description.abstractMicrobial infections are a significant threat to public health and resistances are on the rise, so new antibiotics with novel modes of action are urgently needed. The extracellular zinc metalloprotease collagenase H (ColH) from Clostridium histolyticum is a virulence factor that catalyzes tissue damage, leading to improved host invasion and colonisation. Besides the major role of ColH in pathogenicity, its extracellular localisation makes it a highly attractive target for the development of new antivirulence agents. Previously, we had found that a highly selective and potent thiol prodrug (with a hydrolytically cleavable thiocarbamate unit) provided efficient ColH inhibition. We now report the synthesis and biological evaluation of a range of zinc-binding group (ZBG) variants of this thiol-derived inhibitor, with the mercapto unit being replaced by other zinc ligands. Among these, an analogue with a phosphonate motif as ZBG showed promising activity against ColH, an improved selectivity profile, and significantly higher stability than the thiol reference compound, thus making it an attractive candidate for future drug development.en_US
dc.language.isoenen_US
dc.publisherWiley-VCHen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectStructure-activity relationshipen_US
dc.subjectanti-infectivesen_US
dc.subjectdrug designen_US
dc.subjectmedicinal chemistryen_US
dc.subjectmetalloenzymesen_US
dc.titlePhosphonate as Stable Zinc-binding Group for Inhibitors of Clostridial Collagenase H (ColH) as Pathoblocker Agents.en_US
dc.typeArticleen_US
dc.identifier.eissn1860-7187
dc.contributor.departmentHIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.en_US
dc.identifier.journalChemMedChemen_US
dc.source.journaltitleChemMedChem
dc.source.countryGermany


Files in this item

Thumbnail
Name:
Voos et al.pdf
Size:
1.326Mb
Format:
PDF
Description:
Accepted manuscript

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International